Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Reducing the risks of nuclear war—the role of health professionals128
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells101
Correction to: Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis76
Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma71
Correction: UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P5371
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X60
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance57
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy54
Small extracellular vesicle TGF-β in cancer progression and immune evasion54
P38 kinase in gastrointestinal cancers52
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway51
Platelet activation: a barrier to effective antitumor immunity51
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells50
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 145
Correction to: FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis45
Role of non-coding RNAs in neuroblastoma43
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity39
Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence34
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis34
Ending nuclear weapons, before they end us33
Pan-cancer oncogenic properties and therapeutic potential of SF3B432
Self-replicating messenger RNA based cancer immunotherapy32
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma30
Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer30
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells30
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy29
Pathophysiological role of ion channels and transporters in HER2-positive breast cancer28
Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter28
0.05495810508728